Skip to search formSkip to main contentSkip to account menu

Anti-Arrhythmia Agents

Known as: antiarrhythmia, Anti-arrhythmic Agent [TC], Antiarrhythmic 
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential… 
National Institutes of Health

Related topics

Related topics

49 relations

Narrower (39)

4-hydroxyphenylethanolAcetyldigitoxinsAtenololBepridil
Antiarrhythmic [EPC]In BloodLidocaine Hydrochloride 0.04 MG/MG Topical GelLidocaine Hydrochloride 20 MG/ML Topical Solution

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1988
Highly Cited
1988
Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 2. Mechanism of inhibition by bepridil.
Bepridil, an antiarrhythmic agent, inhibits Na-Ca exchange in cardiac sarcolemmal membrane vesicles (Ki = 30 microM) by a novel… 
Highly Cited
1987
Highly Cited
1987
A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation.
Fourteen patients with established atrial fibrillation (longer than three months) that was refractory to treatment were studied… 
Highly Cited
1986
Highly Cited
1986
Amiodarone-induced enhancement of doxorubicin and 4'-deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo.
The mechanisms of the resistance of intestinal cancer to anthracyclines were studied on an experimental model of rat colon cancer… 
Highly Cited
1982
Highly Cited
1982
Pirmenol, A New Antiarrhythmic Agent: Initial Study of Efficacy, Safety and Pharmacokinetics
Pirmenol (CI-845), a new antiarrhythmic drug, was studied for the first time in humans to establish a minimum effective i.v. dose… 
Highly Cited
1982
Highly Cited
1982
Suppression of Ventricular Arrhythmias by Propafenone, a New Antiarrhythmic Agent, During Acute Myocardial Infarction in the Conscious Dog A Comparative Study with Lidocaine
The responsiveness of ventricular tachycardia (VT) to propafenone, a new antiarrhythmic agent, was evaluated in the conscious dog… 
1982
1982
Antiarrhythmic Drug Combinations in the Treatment of Ventricular Tachycardia Efficacy and Electrophysiologic Effects
Combinations of antiarrhythmic drugs are frequently used to treat refractory ventricular tachycardia (VT), but few scientific… 
Highly Cited
1981
Highly Cited
1981
Antiarrhythmic Efficacy of Encainide in Patients with Refractory Recurrent Ventricular Tachycardia
Encainide is a new agent for treating ventricular arrhythmias. We attempted long-term oral therapy with encainide in 38 patients… 
Highly Cited
1980
Highly Cited
1980
A New Method for Evaluating Antiarrhythmic Drug Efficacy
To develop standards for distinguishing antiarrhythmic drug effect from spontaneous variability of premature ventricular… 
Highly Cited
1979
Highly Cited
1979
Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias
Amiodarone is an antiarrhythmic agent unrelated to other drugs in current use. It has been little used in Britain, and no formal… 
1976
1976
Differences in the cardiac actions of the calcium antagonists verapamil and nifedipine.
1. It was investigated whether the calcium antagonistic coronary drugs verapamil and nifedipine have similar antiarrhythmic…